Matches in SemOpenAlex for { <https://semopenalex.org/work/W3161567981> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- W3161567981 abstract "Background: Pancreatic adenocarcinoma (PDAC) is relatively rare but highly aggressive, with most patients diagnosed once they have metastatic or locally invasive disease. Molecular profiling is being explored as a tool for selecting patients for targeted therapy clinical trials and for assessing whether targeted therapies may be effective in PDAC. Whether molecular profiling is being performed at both academic and community oncology clinics has yet to be examined. Here, we characterized the molecular profiling practice patterns in patients with PDAC in academic versus community practices in Denver, Colorado. Methods: We retrospectively reviewed records of all patients with refractory, metastatic PDAC who were referred to a tertiary clinical trials drug development unit in Denver between 2014 and 2019. Results: Of 77 patients, 41 (55%) were men with a mean age of 65 years (SD, 9.3). Fifty-three patients (69%) were referred from the community and 20 (26%) from academic centers; 4 (5%) were self-referred. A total of 51% received profiling prior to referral; 29 of 50 (58%) were from the community and 10 of 21 (47%) from academic settings. Guardant was the most commonly ordered test (47 of 77; 61%); FoundationOne was the second most common (40 of 77; 52%). Twenty-three of 77 patients (30%) received both Guardant and FoundationOne testing, and 3 of 77 (4%) received Caris MI Profile. One patient received a Mocha assay and another received Ascend/Clarient fluorescence in situ hybridization (FISH). Four patients were self-referred, 2 of whom underwent both Guardant and FoundationOne, 1 who underwent Guardant testing only, and 1 who did not receive any molecular profiling testing. Conclusions: This study characterizes molecular profiling practice patterns in individuals with advanced PDAC who were referred to a tertiary clinical trials drug development unit. Both academic and community physicians were found to order profiling about 50% of the time. Further research is needed to determine impact on clinical trial enrollment and detection of PDAC." @default.
- W3161567981 created "2021-05-24" @default.
- W3161567981 creator A5034303052 @default.
- W3161567981 creator A5041794539 @default.
- W3161567981 creator A5048129323 @default.
- W3161567981 creator A5048334337 @default.
- W3161567981 creator A5090510992 @default.
- W3161567981 date "2021-01-01" @default.
- W3161567981 modified "2023-10-07" @default.
- W3161567981 title "Molecular Profiling Practices in Pancreatic Adenocarcinoma: Academic vs Community Physicians" @default.
- W3161567981 doi "https://doi.org/10.46883/onc.2021.3505.0244" @default.
- W3161567981 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33979117" @default.
- W3161567981 hasPublicationYear "2021" @default.
- W3161567981 type Work @default.
- W3161567981 sameAs 3161567981 @default.
- W3161567981 citedByCount "0" @default.
- W3161567981 crossrefType "journal-article" @default.
- W3161567981 hasAuthorship W3161567981A5034303052 @default.
- W3161567981 hasAuthorship W3161567981A5041794539 @default.
- W3161567981 hasAuthorship W3161567981A5048129323 @default.
- W3161567981 hasAuthorship W3161567981A5048334337 @default.
- W3161567981 hasAuthorship W3161567981A5090510992 @default.
- W3161567981 hasBestOaLocation W31615679811 @default.
- W3161567981 hasConcept C111919701 @default.
- W3161567981 hasConcept C126322002 @default.
- W3161567981 hasConcept C143998085 @default.
- W3161567981 hasConcept C187191949 @default.
- W3161567981 hasConcept C2776135927 @default.
- W3161567981 hasConcept C41008148 @default.
- W3161567981 hasConcept C512399662 @default.
- W3161567981 hasConcept C535046627 @default.
- W3161567981 hasConcept C71924100 @default.
- W3161567981 hasConceptScore W3161567981C111919701 @default.
- W3161567981 hasConceptScore W3161567981C126322002 @default.
- W3161567981 hasConceptScore W3161567981C143998085 @default.
- W3161567981 hasConceptScore W3161567981C187191949 @default.
- W3161567981 hasConceptScore W3161567981C2776135927 @default.
- W3161567981 hasConceptScore W3161567981C41008148 @default.
- W3161567981 hasConceptScore W3161567981C512399662 @default.
- W3161567981 hasConceptScore W3161567981C535046627 @default.
- W3161567981 hasConceptScore W3161567981C71924100 @default.
- W3161567981 hasLocation W31615679811 @default.
- W3161567981 hasLocation W31615679812 @default.
- W3161567981 hasOpenAccess W3161567981 @default.
- W3161567981 hasPrimaryLocation W31615679811 @default.
- W3161567981 hasRelatedWork W10114732 @default.
- W3161567981 hasRelatedWork W10745580 @default.
- W3161567981 hasRelatedWork W12670419 @default.
- W3161567981 hasRelatedWork W16329433 @default.
- W3161567981 hasRelatedWork W17992501 @default.
- W3161567981 hasRelatedWork W19291725 @default.
- W3161567981 hasRelatedWork W3045249 @default.
- W3161567981 hasRelatedWork W5729901 @default.
- W3161567981 hasRelatedWork W6817586 @default.
- W3161567981 hasRelatedWork W8036556 @default.
- W3161567981 isParatext "false" @default.
- W3161567981 isRetracted "false" @default.
- W3161567981 magId "3161567981" @default.
- W3161567981 workType "article" @default.